4.6 Article

Stapling of Peptides Potentiates the Antibiotic Treatment of Acinetobacter baumannii In Vivo

Journal

ANTIBIOTICS-BASEL
Volume 11, Issue 2, Pages -

Publisher

MDPI
DOI: 10.3390/antibiotics11020273

Keywords

stapled antimicrobial peptides; zebrafish larvae infection model; synergy

Funding

  1. European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant [713669]
  2. Dutch Research Counsel (NOW) [16433]
  3. Marie Curie Actions (MSCA) [713669] Funding Source: Marie Curie Actions (MSCA)

Ask authors/readers for more resources

The rising incidence of multidrug resistance in Gram-negative bacteria calls for novel treatment options. One promising approach is the combination of antibiotics with antimicrobial peptides. However, the use of such peptides is challenging due to their susceptibility to proteolytic degradation. This study demonstrates that the introduction of a hydrocarbon staple can enhance the stability and therapeutic potential of antimicrobial peptides without increasing their toxicity or hemolytic activity.
The rising incidence of multidrug resistance in Gram-negative bacteria underlines the urgency for novel treatment options. One promising new approach is the synergistic combination of antibiotics with antimicrobial peptides. However, the use of such peptides is not straightforward; they are often sensitive to proteolytic degradation, which greatly limits their clinical potential. One approach to increase stability is to apply a hydrocarbon staple to the antimicrobial peptide, thereby fixing them in an alpha-helical conformation, which renders them less exposed to proteolytic activity. In this work we applied several different hydrocarbon staples to two previously described peptides shown to act on the outer membrane, L6 and L8, and tested their activity in a zebrafish embryo infection model using a clinical isolate of Acinetobacter baumannii as a pathogen. We show that the introduction of such a hydrocarbon staple to the peptide L8 improves its in vivo potentiating activity on antibiotic treatment, without increasing its in vivo antimicrobial activity, toxicity or hemolytic activity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available